About
Science & Epigenetics
Programs
Newsroom
Contact
Connect
Email
info@zenithepigenetics.com
Call
1 (587) 390-7865
Share
FAQ
Newsroom
News Releases
Presentations & Events
SEDAR Filings
News Releases
2021
2020
2019
2018
2017
2016
2015
2014
2013
Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
March 15, 2021
© 2021 zenithepigenetics |
Legal
|
Privacy